NAP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NAP, covering 2025-03-03 to 2025-03-03. Get the full timeline:
Most recent: Clinical Trial Update: NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC [Phase 2]